Andrew J. Ahmann MD, MSProfessor of Medicine, Oregon Health and Science University; Director, Harold Schnitzer Diabetes Health Center, Portland, Oregon
Dr. Ahmann is a Professor of Medicine at Oregon Health and Science University and the Director of the Harold Schnitzer Diabetes Health Center, a combined pediatric and adult center. Beyond patient care he is active in medical education and clinical research. He received his MD at University of Colorado and completed endocrinology training at Walter Reed Medical Center. His clinical research and publications have addressed new therapies, new technologies and best practices for type 1 and type 2 diabetes. He has served on regional and national committees including the American Diabetes Association (ADA), the Endocrine Society and AACE. He chaired the Oregon State Diabetes Guideline Advisory Group, the Oregon Diabetes Coalition and the Oregon Diabetes Collaborative. He volunteered as camp physician at the Chris Dudley Basketball Camp for Children with Diabetes for two decades. Dr. Ahmann was on the national ADA Professional Practice Committee and the Scientific Sessions Planning Committee. He received the ADA Outstanding Physician Clinician in Diabetes Award in 2018. He serves as the endocrinologist for the Oregon ECHO Diabetes Program. He has served as faculty in multiple international educational programs sponsored by the ADA, ACC and the Endocrine Society.
DisclosuresDr. Ahmann has done research support for DexCon, Lexicon, Medtronic and Novo Nordisk. He was a consultant for DexCon and Novo Nordisk.
Recent Contributions to PracticeUpdate:
- Once-Weekly Insulin Icodec vs Once-Daily Insulin Glargine U100 in Individuals With Basal–Bolus Insulin-Treated Type 2 Diabetes
- Switching to Once-Weekly Insulin Icodec vs Once-Daily Insulin Degludec in Individuals With Basal Insulin–Treated Type 2 Diabetes
- Real-Time vs Intermittent Glucose Monitoring in Type 1 Diabetes